De-escalating Surgery Among Patients with HER2+and Triple Negative Breast Cancer

被引：2

作者：

Tasoulis, Marios-Konstantinos ^{[1
,2
]}

Heil, Joerg ^{[3
]}

Kuerer, Henry M. ^{[4
]}

机构：

[1] Royal Marsden NHS Fdn Trust, Breast Surg Unit, Fulham Rd, London SW3 6JJ, England

[2] Inst Canc Res, Div Breast Canc Res, Old Brompton Rd, London SW7 3RP, England

[3] Heidelberg Univ Hosp, Univ Breast Unit, Dept Obstet & Gynecol, Heidelberg, Germany

[4] Univ Texas MD Anderson Canc Ctr, Dept Breast Surg Oncol, Houston, TX 77030 USA

来源：

CURRENT BREAST CANCER REPORTS | 2022年 / 14卷 / 04期

关键词：

Surgical de-escalation; Breast surgery; Triple negative; HER2; positive; Breast cancer; PATHOLOGICAL COMPLETE RESPONSE; SENTINEL NODE BIOPSY; 20-YEAR FOLLOW-UP; NEOADJUVANT CHEMOTHERAPY; RADICAL-MASTECTOMY; MULTICENTER; TRIAL; IDENTIFICATION; AXILLA; IMPACT;

D O I：

10.1007/s12609-022-00453-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Purpose of Review De-escalation of surgery has been central in the evolution of multidisciplinary management of breast cancer. Advances in oncology and increasing use of neoadjuvant chemotherapy (NACT) have opened opportunities for further surgical de-escalation especially for HER2 + and triple negative (TN) disease. The aim of this review is to discuss the recent data on de-escalation of surgery as well as the future directions. Recent Findings Patients with TN and HER2 + breast cancer with excellent response to NACT would be the ideal candidates for surgical de-escalation. Post-NACT image-guided biopsy, potentially combined with machine learning algorithms, may accurately identify patients achieving pathologic complete response that would be eligible for clinical trials assessing safety of omission of breast and axillary surgery. Multidisciplinary research is required to further support results of preliminary studies. Current data point towards a future when even less or no surgery may be required for exceptional responders.

引用

页码：135 / 141

页数：7

共 55 条

[1]

[Anonymous], AVOIDING SENTINEL LY

[2]

[Anonymous], COMP AXILLARY LYMPH

[3]

[Anonymous], ELIMINATING SURG RAD

[4] Avoiding breast cancer surgery in a select cohort of complete responders to neoadjuvant chemotherapy: The long-term outcomes [J].

Apte, Anuradha ;

Marsh, Simon ;

Chandrasekharan, Sankaran ;

Chakravorty, Arunmoy .

ANNALS OF MEDICINE AND SURGERY, 2021, 66

[5] Association of Low Nodal Positivity Rate Among Patients With ERBB2-Positive or Triple-Negative Breast Cancer and Breast Pathologic Complete Response to Neoadjuvant Chemotherapy [J].

Barron, Alison U. ;

Hoskin, Tanya L. ;

Day, Courtney N. ;

Hwang, E. Shelley ;

Kuerer, Henry M. ;

Boughey, Judy C. .

JAMA SURGERY, 2018, 153 (12) :1120-1126

[6] Primary analysis of NRG-BR005, a phase II trial assessing accuracy of tumor bed biopsies in predicting pathologic complete response (pCR) in patients with clinical/radiological complete response after neoadjuvant chemotherapy (NCT) to explore the feasibility of breast-conserving treatment without surgery [J].

Basik, Mark ;

Cecchini, Reena S. ;

De Los Santos, Jennifer F. ;

Umphrey, Heidi R. ;

Julian, Thomas B. ;

Mamounas, Eleftherios P. ;

White, Julia ;

Lucas, Peter C. ;

Balanoff, Christa ;

Tan, Antoinette R. ;

Weber, Joseph J. ;

Edmonson, David A. ;

Brown-Glaberman, Ursa A. ;

Diego, Emilia J. ;

Teshome, Mediget ;

Matsen, Cindy B. ;

Seaward, Samantha A. ;

Wapnir, Irene L. ;

Wagner, Jamie L. ;

Tjoe, Judy A. ;

Thompson, Alastair M. ;

Wolmark, Norman .

CANCER RESEARCH, 2020, 80 (04)

[7] Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study [J].

Boileau, Jean-Francois ;

Poirier, Brigitte ;

Basik, Mark ;

Holloway, Claire M. B. ;

Gaboury, Louis ;

Sideris, Lucas ;

Meterissian, Sarkis ;

Arnaout, Angel ;

Brackstone, Muriel ;

McCready, David R. ;

Karp, Stephen E. ;

Trop, Isabelle ;

Lisbona, Andre ;

Wright, Frances C. ;

Younan, Rami J. ;

Provencher, Louise ;

Patocskai, Erica ;

Omeroglu, Atilla ;

Robidoux, Andre .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03) :258-U150

[8] Impact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for breast cancer [J].

Boughey, Judy C. ;

Peintinger, Florentia ;

Meric-Bernstam, Funda ;

Perry, Allison C. ;

Hunt, Kelly K. ;

Babiera, Gildy V. ;

Singletary, S. E. ;

Bedrosian, Isabelle ;

Lucci, Anthony ;

Buzdar, Aman U. ;

Pusztai, Lajos ;

Kuerer, Henry M. .

ANNALS OF SURGERY, 2006, 244 (03) :464-470

[9] Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer The ACOSOG Z1071 (Alliance) Clinical Trial [J].

Boughey, Judy C. ;

Suman, Vera J. ;

Mittendorf, Elizabeth A. ;

Ahrendt, Gretchen M. ;

Wilke, Lee G. ;

Taback, Bret ;

Leitch, A. Marilyn ;

Kuerer, Henry M. ;

Bowling, Monet ;

Flippo-Morton, Teresa S. ;

Byrd, David R. ;

Ollila, David W. ;

Julian, Thomas B. ;

McLaughlin, Sarah A. ;

McCall, Linda ;

Symmans, W. Fraser ;

Le-Petross, Huong T. ;

Haffty, Bruce G. ;

Buchholz, Thomas A. ;

Nelson, Heidi ;

Hunt, Kelly K. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (14) :1455-1461

[10] Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and ASCO Guideline [J].

Brackstone, Muriel ;

Baldassarre, Fulvia G. ;

Perera, Francisco E. ;

Cil, Tulin ;

Mac Gregor, Mariana Chavez ;

Dayes, Ian S. ;

Engel, Jay ;

Horton, Janet K. ;

King, Tari A. ;

Kornecki, Anat ;

George, Ralph ;

SenGupta, Sandip K. ;

Spears, Patricia A. ;

Eisen, Andrea F. .

JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (27) :3056-+

← 1 2 3 4 5 6 →